Lo Gullo, A. (2017) “Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis”, Reumatismo, 69(4), pp. 184–188. doi: 10.4081/reumatismo.2017.1013.